"The entire team at Urologix is very proud to see the positive impact on patients' lives our customers are achieving through the use of our technologies and thank them for their efforts to publish their results." stated Greg Fluet, CEO of Urologix. "It was especially compelling to see data from the Portland Veterans Administration where the patients are so deserving of the best care our country can provide. It is our hope that data of this sort showing the benefits of earlier intervention will help increase access to care for both veterans and non-veterans alike as so many men are stuck on chronic medication for years before understanding what alternative options exist." About Urologix Urologix, Inc., based in Minneapolis, develops, manufactures, markets and distributes minimally invasive medical products for the treatment of obstruction and symptoms due to Benign Prostatic Hyperplasia (BPH).